George Clinical – Page 2 – George Clinical

China’s Future in Global Clinical Research

By George Clinical
Industry News

Philip Gregory of George Clinical focuses on China, in a three part series originally published on http://innovations.bbkworldwide.com/part-iii-chinas-future-in-global-clinical-research that discusses developments in the clinical trial landscape of East Asia and Japan. Active international collaboration has facilitated the rise of the Asia-Pacific region in global clinical research. With the world’s largest population, China’s recent changes to their clinical trial processes and […]

January 19th, 2016

Overcoming the Diversity in the South East Asian Region for a Global Clinical Trial

By George Clinical
Industry News

Sponsors are increasingly seeking emerging areas to conduct clinical trials for new patient pools and better recruitment. However, successful implementation of a global clinical trial in areas such as South East Asia requires operational strategies that circumvents the inherent diversity of these regions. In these regions, language, culture, infrastructure and resources are very different from […]

January 5th, 2016

A promising drug shows results in reducing the effects of Alzheimer’s disease

By George Clinical
Research

Alzheimer’s disease is currently the largest unmet medical need in neurology. More than 44 million people live with dementia worldwide, with Alzheimer’s being the most common form. As aging populations expand, it is critical that better treatments become available. George Clinical is currently managing a clinical trial in Australia of a new drug whose preliminary […]

November 17th, 2015

Working with CRM to move Malaysia forward

The Malaysian government has committed funding to improve the healthcare systems in order to further support clinical research. Clinical Research Malaysia (CRM) is a non-profit organisation – wholly owned by the government of Malaysia, which intends to develop infrastructure for the Clinical Research Centre networks, and be able to support global industry sponsored research (ISR) […]

October 21st, 2015

Outsourcing criteria within the Asia-Pacific

George Clinical (GC) conducted a brief survey on sponsors who are currently not a customer of GC. 30 companies were surveyed by GC’s Business Development Managers across six countries which included the United States, China, Australia, Korea, United Kingdom and Israel. The primary objective of the survey was to determine the services and countries that were important […]

September 3rd, 2015

George Clinical Maintains Below Industry Average Staff Turnover

The cost of employee turnover in a Clinical Research Organisation (CRO) is high, as it weakens the relationship with the project sponsor. Research shows that in 2012, the CRO industry in the United States experienced a 12.5% voluntary turnover, compared to an average national voluntary turnover rate of 1.5%. During the 2015 financial year, George Clinical […]

September 3rd, 2015

George Clinical In China Celebrates Two Years As An Independent CRO

George Clinical in China recently celebrated its second anniversary as an independent entity in China. Although George Clinical has been conducting Phase 11 to Phase IV studies in China for over 8 years, previously it was incorporated into The George Institute in China – but now operates as a separate legal entity. The last two […]

August 26th, 2015

The George Institute’s Profile Featured in The Lancet

The George Institute was recently profiled in The Lancet; revered as one of the most prestigious, peer reviewed medical journals in the world. The Lancet Vol. 385 April 18, 2015 The feature article in The Lancet spoke of the Institute’s 16 year history from inception to the present time, where the George Institute is known […]

June 26th, 2015

Glenn Kerkhof appointed as Chairman of the Board

March 24th, 2015

George Clinical Intro Video

Who is George Clinical? Watch this quick video to find out more.

May 27th, 2014